glp-1 receptor agonists brand names are commonly used medications to treat Type 2 Diabetes. They are subcutaneous injections, so many patients mistaken these medications for insulin. However, GLP-1's are very different. They work primarily on List of GLP-1 Receptor Agonists

GLP-1 RAs promote weight loss [41], hence our findings of an increase in weight with GLP-1 RA therapy at 5 years was interesting

The protective cardiovascular effects of GLP-1RAs can be through improving glycemic control, as reducing HbA1c can improve blood pressure, body weight, hyperlipoproteinemia, and inflammation

obesity rates in over a decade 1

A meta-analysis of seven SURPASS clinical trials in participants with T2DM showed the hazard ratios comparing tirzepatide versus controls of 0.80 (95% CI, 0.57 1.11) for 4-MACE, 0.90 (95% CI, 0.50 1.61) for cardiovascular death, and 0.80 (95% CI, 0.51 1.25) for all-cause mortality (264)

Skip to Content About Us Toggle About Us Menu Mission People News Our Work Contact Fair Allocation of GLP-1 and Dual GLP-1GIP Receptor Agonists Emanuel EJ, Dellgren JL, McCoy MS, Persad G LINK TO MANUSCRIPT Fair-Allocation Framework for GLP-1 and Dual GLP-1GIP Receptor Agonists (NEJM, 2024) Menu About Us About Us Mission People News Our Work Contact twitter youtube Search Search

The goal is to use enough medication to support meaningful clinical improvement while preserving nutrition, muscle, function, and long-term adherence